Callan JMB Inc. (CJMB) CEO Wayne D. Williams discloses December $1.65 share purchases

Rhea-AI Filing Summary

Callan JMB Inc. CEO, Chairman and President Wayne D. Williams, who is also a director and 10% owner, reported insider purchases of the company’s common stock on 12/10/2025 and 12/11/2025. The transactions used code “P” for purchases.

Through Health Hero America, LLC, which he solely owns, he acquired 13,689 and 30,856 shares at $1.65 per share, bringing that entity’s beneficial holdings to 68,545 shares after the later trade. He also reports beneficial ownership of 2,262,500 shares directly and 25,625 shares indirectly through Warehouse Asset Management, LLC, in which he holds a 41% ownership interest.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Williams Wayne D

(Last) (First) (Middle)

C/O CALLAN JMB INC. 244 FLIGHTLINE DRIVE

(Street)

SPRING BRANCH TX 78070

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CALLAN JMB INC. [ CJMB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	CEO, Chairman and President

3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								2,262,500	D
Common Stock								25,625	I	By Warehouse Asset Management, LLC(1)
Common Stock	12/10/2025		P		13,689	A	$1.65	38,689	I	By Health Hero America, LLC(2)
Common Stock	12/11/2025		P		30,856	A	$1.65	68,545	I	By Health Hero America, LLC(2)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Mr. Williams holds a 41% ownership interest in Warehouse Asset Management, LLC.

2. Mr. Williams is the sole owner of Health Hero America, LLC.

	/s/ Wayne D. Williams	12/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider stock transactions did CJMB report for Wayne D. Williams?

Wayne D. Williams reported two “P” code purchases of Callan JMB Inc. (CJMB) common stock: 13,689 shares on 12/10/2025 and 30,856 shares on 12/11/2025, each at $1.65 per share, through Health Hero America, LLC.

How many CJMB shares does Wayne D. Williams beneficially own after these trades?

After the reported transactions, Wayne D. Williams reports beneficial ownership of 2,262,500 shares of CJMB common stock directly, 25,625 shares indirectly through Warehouse Asset Management, LLC, and 68,545 shares indirectly through Health Hero America, LLC.

Through which entities does Wayne D. Williams hold indirect CJMB ownership?

He holds CJMB shares indirectly through Warehouse Asset Management, LLC, where he has a 41% ownership interest, and through Health Hero America, LLC, which he solely owns.

What is Wayne D. Williams’s role at Callan JMB Inc. (CJMB)?

Wayne D. Williams serves as CEO, Chairman and President of Callan JMB Inc., and is also a director and a reported 10% owner.

What is the earliest transaction date reported in this CJMB insider filing?

The earliest transaction date reported for Wayne D. Williams’s CJMB trades is 12/10/2025.

Under which SEC rules was this CJMB insider report filed?

The report was filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 and Section 30(h) of the Investment Company Act of 1940.